Network Ad
🏈 Bleacher Wire — Sports news & hot takes Explore
Loading...
0

When it comes to supporting gut health, muscle recovery, and immune function, L-glutamine supplements are a popular choice for many individuals.  As an essential amino acid, L-glutamine plays a crucial role in maintaining a healthy digestive system, repairing tissues, and boosting overall welln…

0

In an enlightening conversation with Phil Newman of Longevity Technology, Dr. Michael Greger, founder of NutritionFacts.org, shared valuable thoughts on the links between diet, health, and a longer, more vibrant life.  Known for his evidence-based approach to nutrition, Dr. Greger has made it h…

0

Kayla Barnes-Lentz is a trailblazer in the world of brain health and biohacking, combining precision medicine with innovative wellness strategies.  Founder of Brain Upgraded and LYV The Wellness Space, she’s dedicated to helping others optimize their health and achieve longevity.  In a recent i…

0

Biopharma veteran to advise Sei’s $65m Open Science Fund on scaling decentralized research for longevity, health and biotech. Sapien Capital, the decentralized science (DeSci) investment arm of the Sei Foundation, has appointed Dr Michael Baran, Partner at Pfizer Ventures, as a strategic advisor. Hi…

0

Biotech gears up for potential Fertilo approval while accelerating development of menopause-targeting therapies. Women’s health biotech Gameto has secured $44 million in Series C financing to advance its work in stem cell–derived therapies for reproductive health. The company says the funding will a…

0

“You have to understand a person's belief if you want to address it,” Deva Sharma says on the “First Opinion Podcast” about requests for unvaccinated donor blood.

0

Sleep tech firm is harnessing advanced sensors and AI to turn your bed into a preventive health device. US sleep technology company Eight Sleep has raised $100 million in new funding to accelerate its push beyond consumer tech into preventive health and medical applications. The company, which devel…

0

Longevity platform drops pricing to $199 a year for ‘concierge level’ preventive health model that analyzes 100+ blood biomarkers. San Francisco-based longevity healthtech Superpower has launched a $199 annual membership as it aims to bring its “concierge-level” preventative healthcare model to a wi…

0

Analyzing 250 biomarkers in a single test, Molecular You aims to bring ‘scientific discipline and clinical-grade rigor’ to consumer wellness. Preventive health startup Molecular You has raised $5 million in Series A financing to scale its predictive health platform. Based in Portland, Oregon, and Va…

0

Neu Health, a precision neurology platform focused on Parkinson’s disease and dementia care, has been accepted into the six-month Global Incubator Programme (GIP): USA HealthTech – Medical Devices. The programme, which starts in September 2025 and runs through March 2026, is run by Innovate UK in pa…

0

Mesoblast has reported that the commercial launch of Ryoncil (remestemcel-L-rknd), its FDA-approved mesenchymal stromal cell (MSC) product, was a focal point at recent global healthcare conferences in New York. According to the company, the product is the first FDA-approved MSC therapy, approved for…

0

Generative approach trained on UK and Danish data estimates disease risk over time and hints at a new era for prevention. Imagine being able to map a person’s likely health trajectory twenty years into the future, not with certainty, but with probabilities calibrated across hundreds of possible cond…

0

First-patient dosing in AMETHYST comes five days after a Crystalys rival, Swedish Orphan Biovitrum (Sobi), announced positive Phase III data for pozdeutinurad, a treatment for progressive gout which like dotinurad is a next-generation, once-daily oral URAT1 inhibitor. The post Attacking Gout: Cryst…

0

Deepcell, a company specialising in AI-powered, label-free single cell morphology profiling and sorting, will provide its REM-I platform to integrate into InGel Therapeutics’ therapeutic development pipeline. The companies said the REM-I platform enables high-dimensional morphological insights that …

0

Eyenuk has secured deployment of its EyeArt® AI Eye Screening System within Norway’s South-Eastern Regional Health Authority, marking the first national health system adoption of autonomous AI for eye disease detection, the company said. The initiative, facilitated by Human Bytes, aims to increase r…

0

In this thought leadership article, Erik Terjesen of Silicon Foundry explores how AI has the potential to transform clinical trials, while outdated data systems continue to limit progress. Although AI can help shorten timelines and improve decision-making, it is not a cure-all—it cannot fix flawed t…